CIMIT Gives Academic Community Voice In Least Burdensome Debate
This article was originally published in The Gray Sheet
Executive Summary
The Center for Innovative Minimally Invasive Therapy (CIMIT) is planning a public forum that will convene representatives from FDA, industry and the academic community to discuss the "least burdensome" process for device evaluation in several specific product areas.